SCHEMBL4423867

SCHEMBL4423867

CCOC(=O)c1ccc2nc(SC)nc(-c3cccc(OC)c3)c2c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LHCGR P22888 3/20 0.48
TSHR P16473 1/20 0.47
ALDH1A1 P00352 8/20 0.46
KDM4E B2RXH2 7/20 0.46
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
TP53 P04637 2/20 0.45
CSNK1D P48730 1/20 0.43
USP2 O75604 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 2/20 0.40
FOS P01100 1/20 0.40
JUN P05412 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
DHODH Q02127 1/20 0.40
TDP1 Q9NUW8 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432167 0.90 LHCGR (0.54) LHCGRTSHRALDH1A1KDM4EHPGD
SCHEMBL4430395 0.87 LHCGR (0.51) LHCGRTSHRALDH1A1KDM4EHPGD
SCHEMBL7143226 0.86 LHCGR (0.51) LHCGRTSHRALDH1A1KDM4EHPGD
SCHEMBL4428948 0.86 LHCGR (0.52) LHCGRTSHRKDM4EMAPTLMNA
SCHEMBL4425051 0.79 KDM4E (0.55) LHCGRTSHRALDH1A1KDM4EHPGD
SCHEMBL4421572 0.78 SMN1; SMN2 (0.50) LHCGRTSHRALDH1A1KDM4EHPGD
SCHEMBL4418728 0.78 LHCGR (0.57) LHCGRTSHRKDM4EMAPT
SCHEMBL4423898 0.78 LHCGR (0.55) LHCGRTSHRKDM4EHSD17B10MAPT
SCHEMBL4423871 0.78 LHCGR (0.48) LHCGRTSHRALDH1A1KDM4EHPGD
SCHEMBL4327613 0.76 LHCGR (0.77) LHCGRTSHRALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618963-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2009-11-17 US disclosed
EP-1886999-A2 Bicyclic heteroaromatic compound N.V. Organon (NL) 2008-02-13 EP disclosed
US-20070197527-A1 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-08-23 US disclosed
US-7229990-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-06-12 US disclosed
CN-1247594-C Bicyclic heteroaromatic compounds OKZO NOBEL N V (NL) 2006-03-29 CN disclosed
CN-1462273-A Bicyclic heteroaromatic compounds OKZO NOBEL N V (NL) 2003-12-17 CN disclosed
US-20030225113-A1 Bicyclic heteroaromatic compounds MERCK SHARP & DOHME B.V. (NL) 2003-12-04 US disclosed
EP-1322651-A1 BICYCLIC HETEROAROMATIC COMPOUNDS Akzo Nobel N.V. (NL) 2003-07-02 EP disclosed
WO-2002024703-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AKZO NOBEL N.V. (NL) 2002-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225113-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 13/4885TSHR 1000/4885ALDH1A1 1372/4885
US-20070197527-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 10/4885TSHR 517/4885ALDH1A1 1340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.